Thymosin Beta-4 (Tβ4)
43-Amino Acid Regenerative Peptide | Tissue Repair & Healing
Community Research
Join others researching Thymosin Beta-4 — share findings, ask questions, and learn from real experiences
Naturally occurring 43-amino acid peptide crucial for tissue repair, wound healing, and cellular regeneration. Promotes angiogenesis, reduces inflammation, and supports cell migration and differentiation.
Direct systemic delivery provides optimal bioavailability and distribution to target tissues for comprehensive regenerative effects including angiogenesis, cell migration, and differentiation.
Molecular Data
Ac
Position 1
Serine
Position 2
Aspartic Acid
Position 3
Lysine
Position 4
Proline
Position 5
Position 6
Methionine
Position 7
Alanine
Position 8
Glutamic Acid
Position 9
Isoleucine
Position 10
Position 11
Position 12
Phenylalanine
Position 13
Position 14
Position 15
Position 16
Position 17
Leucine
Position 18
Position 19
Position 20
Threonine
Position 21
Position 22
Position 23
Glutamine
Position 24
Position 25
Position 26
Asparagine
Position 27
Position 28
Position 29
Position 30
Position 31
Position 32
Position 33
Position 34
Position 35
Position 36
Position 37
Position 38
Position 39
Position 40
Position 41
Glycine
Position 42
Position 43
Position 44
Research Indications
Clinical trials show 67% complete healing versus 25% placebo in pressure ulcers.
Enhanced tissue regeneration and reduced healing time in surgical wounds.
Accelerated recovery in muscle, tendon, and ligament injuries.
Phase 2b trials show 43% reduction in infarct size when given within 6 hours.
Improved neurological outcomes and functional recovery in animal models.
Dosing Protocols
Systemic regenerative effects with proven clinical efficacy and optimal bioavailability.
Acute Wound Healing
1.6mg
Daily
SubQ
Cardiac Protection
42mg
Single dose
IV bolus within 6 hours of MI
Chronic Tissue Repair
6mg
Twice weekly
Neurological Recovery
30mg
Three times over 72 hours
IV infusion
General Regeneration
2-5mg
Daily or every other day
Reconstitution Instructions
Thymosin β4 lyophilized powder (sterile vial)
Bacteriostatic water for injection (BWFI)
Sterile syringes and needles
Alcohol swabs and sterile gauze
1 Allow lyophilized powder to reach room temperature before reconstitution
2 Add bacteriostatic water slowly to vial wall, avoiding direct powder contact
3 Gently swirl (do not shake vigorously) until completely dissolved
4 Inspect solution for clarity—should be clear and colorless
5 Store reconstituted solution at 2-8°C and use within 14 days
6 Use proper aseptic technique and rotate injection sites
Interactions
What to Expect
Side Effects & Safety
Common Side Effects
Mild injection site reactions
Local inflammation at injection sites
Stop Signs - Discontinue if:
Severe injection site reactions or persistent inflammation
Signs of systemic allergic reaction (rash, breathing difficulty)
Unexpected cardiovascular symptoms during treatment
Any signs of infection at injection sites
Contraindications
Active chemotherapy treatment
Severe systemic allergies to peptides
Quality Checklist
Good Signs
Clear, colorless solution when reconstituted
Proper sterile packaging with intact seals
Certificate of analysis showing >98% purity
Appropriate molecular weight confirmed via HPLC/MS
Warning Signs
Room temperature storage claims—legitimate product requires refrigeration after reconstitution
Bad Signs
Cloudy or discolored solution indicating degradation
Crystallization after reconstitution suggesting improper storage
Frequently Asked Questions
Is Thymosin Beta-4 effective for dry eye or only for wounds?
Thymosin Beta-4 eye drops (0.1% RGN-259) showed Phase 2 efficacy for severe dry eye with significant symptom improvements lasting 28 days post-treatment. Phase 3 trials for neurotrophic keratopathy demonstrated corneal healing and comfort improvements, indicating efficacy beyond general wound healing.
Can Thymosin Beta-4 help with muscle recovery after surgery?
Yes, clinical trials showed Thymosin Beta-4 accelerates post-surgical wound healing by approximately one month in pressure and venous ulcers. This healing acceleration extends to post-surgical tissue repair, making it relevant for accelerating recovery from surgical trauma and improving biomechanical tissue properties.
Why use Thymosin Beta-4 instead of the TB-500 fragment for healing?
Thymosin Beta-4 (full 43 amino acids) provides comprehensive regenerative effects with proven clinical efficacy. TB-500 (7-amino-acid fragment) is more economical and stable. Full-length offers more robust Phase 2 clinical data; fragment offers cost efficiency - both work, choose based on budget and evidence requirements.
Can Thymosin Beta-4 improve cardiac function after a heart attack?
Phase 2b trials showed 43% reduction in heart attack infarct size when Thymosin Beta-4 was administered within 6 hours. It promotes cardiomyocyte migration and survival while stimulating coronary vasculogenesis, indicating potential for cardiac protection, though larger trials are needed for clinical approval.
References
72 subjects showing significant positive effects on ocular discomfort and corneal staining with excellent safety profile.
First-in-human study establishing safety and pharmacokinetics in healthy volunteers with no dose-limiting toxicity.
First human study in heart attack patients demonstrating potential clinical benefits in repairing damaged tissue.
Complete clearing of persistent corneal defects in most subjects using topical formulation.
Related Peptides
TB-500 is the bioactive fragment of Thymosin β4. Combined use provides full-length peptide benefits plus concentrated bioactive effects.
Complementary healing mechanisms—Tβ4 promotes cell migration and angiogenesis while BPC-157 enhances gastric protection.
Disclaimer
This information is for educational and research purposes only. Consult a healthcare professional before use.